![Pete Kang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Pete Kang worked as a Director at Quadrant Biosciences, Inc. and as a Vice President at TStone Corp.
in 2012.
Eerdere bekende functies van Pete Kang
| Bedrijven | Functie | Einde |
|---|---|---|
TStone Corp.
 TStone Corp. Investment ManagersFinance Tstone is an active manager which provides equity funding for buyout stage capital requirement. The firm targets companies operating in industries such as education, digital content, primarily targeting online games, online education, media/entertainment and related infrastructure and technology with enterprise value under KRW 500 billion. TStone typically takes majority stakes and sit in board seat. | Private Equity Investor | 31-12-2012 |
Quadrant Biosciences, Inc.
 Quadrant Biosciences, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
TStone Corp.
TStone Corp. Investment ManagersFinance Tstone is an active manager which provides equity funding for buyout stage capital requirement. The firm targets companies operating in industries such as education, digital content, primarily targeting online games, online education, media/entertainment and related infrastructure and technology with enterprise value under KRW 500 billion. TStone typically takes majority stakes and sit in board seat. | Finance |
Quadrant Biosciences, Inc.
Quadrant Biosciences, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
